Literature DB >> 10908260

Failure of thrombolysis: experience with a policy of early angiography and rescue angioplasty for electrocardiographic evidence of failed thrombolysis.

A G Sutton1, P G Campbell, E D Grech, D J Price, A Davies, J A Hall, M J Stewart, M A de Belder.   

Abstract

OBJECTIVE: To assess the outcome of a policy of emergency coronary angiography with or without rescue angioplasty in patients with acute myocardial infarction and ECG evidence of failed reperfusion after thrombolysis.
DESIGN: A cohort study.
SETTING: Regional cardiothoracic unit. PATIENTS: 197 patients with acute myocardial infarction fulfilling a simple ECG criterion of failed reperfusion.
INTERVENTIONS: Emergency coronary angiography proceeding to rescue angioplasty for inadequate antegrade flow. MAIN OUTCOME MEASURES: Hospital mortality for all 197 patients; incidence of successful and failed rescue angioplasty; need for additional revascularisation in those receiving rescue angioplasty compared with those not treated in this way.
RESULTS: 197 patients had emergency angiography for ECG evidence of failed reperfusion; 156 patients received immediate rescue angioplasty. Overall hospital mortality for those undergoing rescue angioplasty was 11.5%. Rescue angioplasty achieved TIMI 2 (11) or TIMI 3 (124) in 135 patients, who had a hospital mortality of 5.9%. Failure to achieve at least TIMI 2 flow following rescue angioplasty occurred in 21 patients, with a hospital mortality of 48%. In the 41 patients in whom immediate rescue angioplasty was not performed, reinfarction or requirement for revascularisation occurred in 37%. Reinfarction occurred in three patients (1.9%) who had immediate rescue angioplasty. Hospital mortality for the whole cohort was 10.7%.
CONCLUSIONS: A policy of emergency coronary angiography proceeding to rescue angioplasty where appropriate reduces mortality in a high risk group to a level less than expected for patients with acute myocardial infarction and ECG evidence of failed reperfusion. Unsuccessful rescue angioplasty is associated with a high mortality.

Entities:  

Mesh:

Year:  2000        PMID: 10908260      PMCID: PMC1760929          DOI: 10.1136/heart.84.2.197

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  26 in total

1.  Contribution of stenting to the results of rescue PTCA.

Authors:  C Cafri; A E Denktas; E Crystal; R Ilia; A Battler
Journal:  Catheter Cardiovasc Interv       Date:  1999-08       Impact factor: 2.692

2.  What do we do when thrombolysis fails? A United Kingdom survey.

Authors:  B D Prendergast; A Shandall; M B Buchalter
Journal:  Int J Cardiol       Date:  1997-08-29       Impact factor: 4.164

3.  Failure of thrombolysis by streptokinase: detection with a simple electrocardiographic method.

Authors:  A G Sutton; P G Campbell; D J Price; E D Grech; J A Hall; A Davies; M J Stewart; M A de Belder
Journal:  Heart       Date:  2000-08       Impact factor: 5.994

4.  Intraaortic balloon pumping as adjunctive therapy to rescue coronary angioplasty after failed thrombolysis in anterior wall acute myocardial infarction.

Authors:  M Ishihara; H Sato; H Tateishi; T Kawagoe; Y Shimatani; S Kurisu; K Sakai
Journal:  Am J Cardiol       Date:  1995-07-01       Impact factor: 2.778

5.  Change in ST segment elevation 60 minutes after thrombolytic initiation predicts clinical outcome as accurately as later electrocardiographic changes.

Authors:  I F Purcell; N Newall; M Farrer
Journal:  Heart       Date:  1997-11       Impact factor: 5.994

6.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Authors:  J S Hochman; L A Sleeper; J G Webb; T A Sanborn; H D White; J D Talley; C E Buller; A K Jacobs; J N Slater; J Col; S M McKinlay; T H LeJemtel
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

7.  Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Global Use of Strategies To Open occluded coronary arteries.

Authors:  J M Miller; R Smalling; E M Ohman; C Bode; A Betriu; N S Kleiman; J S Schildcrout; E Bastos; E J Topol; R M Califf
Journal:  Am J Cardiol       Date:  1999-10-01       Impact factor: 2.778

8.  Aortic counterpulsation may improve late patency of the occluded coronary artery in patients with early failure of thrombolytic therapy.

Authors:  T Kono; H Morita; T Nishina; M Fujita; H Onaka; Y Hirota; K Kawamura; A Fujiwara
Journal:  J Am Coll Cardiol       Date:  1996-10       Impact factor: 24.094

9.  A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction.

Authors:  W W O'Neill; R Weintraub; C L Grines; T B Meany; B R Brodie; H Z Friedman; R G Ramos; V Gangadharan; R N Levin; N Choksi
Journal:  Circulation       Date:  1992-12       Impact factor: 29.690

10.  Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction.

Authors:  S G Ellis; E R da Silva; G Heyndrickx; J D Talley; C Cernigliaro; G Steg; C Spaulding; M Nobuyoshi; R Erbel; C Vassanelli
Journal:  Circulation       Date:  1994-11       Impact factor: 29.690

View more
  2 in total

1.  One year results of the Middlesbrough early revascularisation to limit infarction (MERLIN) trial.

Authors:  A G C Sutton; P G Campbell; R Graham; D J A Price; J C Gray; E D Grech; J A Hall; A A Harcombe; R A Wright; R H Smith; J J Murphy; A Shyam-Sundar; M J Stewart; A Davies; N J Linker; M A de Belder
Journal:  Heart       Date:  2005-10       Impact factor: 5.994

2.  Rescue percutaneous coronary intervention for failed thrombolysis: results from a district general hospital.

Authors:  K P Balachandran; J Miller; A C H Pell; B D Vallance; K G Oldroyd
Journal:  Postgrad Med J       Date:  2002-06       Impact factor: 2.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.